These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14154179)

  • 1. DOES TREATMENT WITH THIO-TEPA (TRIETHYLENETHIOPHOSPHORAMIDE) PREDISPOSE TO SECONDARY GAS GANGRENE IN PERSONS WITH CARCINOMATOSIS?
    DOYLE E; CHENAULT EM; HOFFMAN GG; HARDING HB
    Aerosp Med; 1964 Jun; 35():576-9. PubMed ID: 14154179
    [No Abstract]   [Full Text] [Related]  

  • 2. [INFECTIOUS PROCESSES IN THE COURSE OF ADMINISTERING TRIETHYLENETHIOPHOSPHORAMIDE TO NORMAL RATS AND DOGS].
    SOERENSEN B; ZEZZANETO L; CORREA HC
    Rev Bras Cir; 1964 Feb; 47():103-7. PubMed ID: 14137147
    [No Abstract]   [Full Text] [Related]  

  • 3. A STUDY OF THE MECHANISMS OF GRANULOCYTOPENIA.
    MAUER AM; KRILL CE
    Ann N Y Acad Sci; 1964 Feb; 113():1003-8. PubMed ID: 14120502
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of triethylenethiophosphoramide (Thio-TEPA) in the treatment of metastatic carcinoma of the breast.
    KUWAYTI K; HILTON JH
    Can Med Assoc J; 1963 Mar; 88(10):528-9. PubMed ID: 13927682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic effect of triethylenethiophosphoramide on the recurrence rate of superficial bladder tumors.
    Mukamel E; Zitron S; Nissenkorn I; Servadio C
    Isr J Med Sci; 1980; 16(9-10):714-6. PubMed ID: 6776072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotransformation of N,N',N''-triethylenethiophosphoramide: oxidative desulfuration to yield N,N',N''-triethylenephosphoramide associated with suicide inactivation of a phenobarbital-inducible hepatic P-450 monooxygenase.
    Ng SF; Waxman DJ
    Cancer Res; 1990 Feb; 50(3):464-71. PubMed ID: 2105156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CHRONIC LYMPHADENOSIS AND CANCER OF THE ESOPHAGUS].
    IVANOVA TT
    Tr Leningr Sanitarnogig Med Inst; 1963; 83():134-5. PubMed ID: 14148490
    [No Abstract]   [Full Text] [Related]  

  • 8. Triethylenethiophosphoramide therapy complicated by overwhelming infection with Clostridium welchii; report of two cases.
    MOORE GE; WATSON TG
    Cancer; 1957; 10(2):246-9. PubMed ID: 13426982
    [No Abstract]   [Full Text] [Related]  

  • 9. [STUDY OF VARIOUS ORGANIC CHANGES PRODUCED BY ANTIBLASTIC CHEMOTHERAPY ADMINISTERED TO DOGS IN HIGH DOSES].
    ZEZZANETO L; SOERENSEN B; SALIBA AM; CORREA HC
    Rev Bras Cir; 1963 Oct; 46():292-6. PubMed ID: 14114220
    [No Abstract]   [Full Text] [Related]  

  • 10. Intrathecal N, N', N"-triethylenethiophosphoramide [thio-TEPA (NSC 6396)] in the treatment of malignant meningeal disease: phase I-II study.
    Gutin PH; Weiss HD; Wiernik PH; Walker MD
    Cancer; 1976 Oct; 38(4):1471-5. PubMed ID: 825215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N,N',N''-triethylenethiophosphoramide (thio-TEPA) oxygenation by constitutive hepatic P450 enzymes and modulation of drug metabolism and clearance in vivo by P450-inducing agents.
    Ng SF; Waxman DJ
    Cancer Res; 1991 May; 51(9):2340-5. PubMed ID: 1707751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The binding of thio-TEPA in human serum and to isolated serum protein fractions.
    Hagen B; Nilsen OG
    Cancer Chemother Pharmacol; 1987; 20(4):319-23. PubMed ID: 3121202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [METASTATIC CARCINOMA OF THE MAMMARY GLAND TREATED WITH TRIETHYLENOTHIOPHOSPHORAMIDE. STUDY OF 10 PATIENTS].
    CUEVASHERNANDEZ P
    Prensa Med Mex; 1963 Oct; 28():306-8. PubMed ID: 14107394
    [No Abstract]   [Full Text] [Related]  

  • 14. EFFECT OF SPLENECTOMY ON TOLERANCE TO THIO-TEPA.
    HIGGINS GA; FLYNN T; GILLESPIE J
    Arch Surg; 1964 Apr; 88():627-32. PubMed ID: 14107014
    [No Abstract]   [Full Text] [Related]  

  • 15. [ON SOME HEMATOMEDULLARY CHANGES DURING ANTIBLASTIC THERAPY, WITH SPECIAL REFERENCE TO THIO-TEPA. PRELIMINARY NOTE].
    BONERA E; CAPRETTI G
    Minerva Radiol Fisioter Radiobiol; 1964; 16():353-5. PubMed ID: 14187607
    [No Abstract]   [Full Text] [Related]  

  • 16. Absorption and fate of C14-labeled N,N',N''-triethylenethiophosphoramide (thio-TEPA) in humans and dogs.
    MELLETT LB; HODGSON PE; WOODS LA
    J Lab Clin Med; 1962 Nov; 60():818-25. PubMed ID: 13934695
    [No Abstract]   [Full Text] [Related]  

  • 17. Single and repeated dose pharmacokinetics of thio-TEPA in patients treated for ovarian carcinoma.
    Hagen B; Walseth F; Walstad RA; Iversen T; Nilsen OG
    Cancer Chemother Pharmacol; 1987; 19(2):143-8. PubMed ID: 3105905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [TERATOGENIC EFFECT OF A COMBINATION OF FASTING AND THIO-TEPA ADMINISTRATION IN PREGNANT MICE].
    NISHIKAWA M
    Kaibogaku Zasshi; 1964 Dec; 39():252-7. PubMed ID: 14277859
    [No Abstract]   [Full Text] [Related]  

  • 19. [MATERNAL AGE OF MICE AND THE ADMINISTRATION OF THIO-TEPA DURING PREGNANCY AS RELATED TO THE MALFORMATION OF THE FETUS].
    NANJO H
    Kaibogaku Zasshi; 1964 Dec; 39():258-62. PubMed ID: 14277860
    [No Abstract]   [Full Text] [Related]  

  • 20. Triethylenethiophosphoramide (thio-tepa) in the treatment of neoplastic disease.
    ULTMANN JE; HYMAN GA; CRANDALL C; NAUJOKS H; GELLHORN A
    Cancer; 1957; 10(5):902-11. PubMed ID: 13472635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.